help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by OCHOA, L.
Right arrow Articles by MINNEAR, F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by OCHOA, L.
Right arrow Articles by MINNEAR, F. L.
Am. J. Respir. Crit. Care Med., Volume 156, Number 4, October 1997, 1247-1255

Contrasting Effects of Hypochlorous Acid and Hydrogen Peroxide on Endothelial Permeability
Prevention with cAMP Drugs

LUIS OCHOA, GREGORY WAYPA, JOHN R. MAHONEY Jr., LUIS RODRIGUEZ, and FRED L. MINNEAR

Departments of Physiology and Cell Biology, Pediatrics, and Experimental and Molecular Pathology, Albany Medical College, Albany, New York

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Activated polymorphonuclear leukocytes generate a cascade of reduced oxygen metabolites. In addition to their antimicrobial role, hydrogen peroxide (H2O2) and hypochlorous acid (HOCl) function as inflammatory mediators and increase the protein permeability of the vascular endothelium. The objectives of the present study were to compare the effects of H2O2 and HOCl with respect to relative potencies and the time course and magnitude of changes in cell shape and permeability of endothelial cell monolayers derived from bovine pulmonary artery, to determine if HOCl produced by conversion of H2O2 with myeloperoxidase and Cl- produces comparable results as the direct administration of HOCl, and to show that adenosine 3',5'-cyclic monophosphate (cAMP)-enhancing agents can prevent the increased endothelial permeability induced by HOCl and H2O2. HOCl given directly or produced by myeloperoxidase, H2O2, and Cl- caused faster and greater changes in cell shape (cell retraction), electrical resistance, and protein permeability (125I-labeled albumin clearance) of endothelial cell monolayers than induced by H2O2. HOCl (10 to 100 µM) induced these changes within 1 to 3 min, whereas H2O2 (50 to 400 µM) required ~ 30 min. 8-Bromo-cAMP prevented the increased endothelial protein permeability induced by HOCl or H2O2, but isoproterenol only prevented the H2O2 response. Thus, HOCl at a much lower concentration caused a faster and greater increase in endothelial permeability in vitro than H2O2, and an increased intracellular level of cAMP prevented the increased permeability induced by either oxidant.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

An increase in vascular endothelial permeability to protein and the development of pulmonary edema are characteristic features of the lung pathophysiology associated with inflammation, embolism, sepsis, and trauma. Polymorphonuclear leukocytes have been implicated in the pathogenesis as these cells when activated produce toxic, reactive oxygen metabolites and proteases that can increase the pulmonary vascular permeability to the movement of water and protein leading to pulmonary edema and the onset of acute respiratory distress syndrome. Upon activation, these cells assemble a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase on the cell surface and generate a cascade of reactive oxygen metabolites that include superoxide radical (O-2), hydrogen peroxide (H 2O2), hypochlorous acid (HOCl), hydroxyl radical (· OH), and peroxynitrite radical (ONOO-). The first four of these oxidants have been reported to increase endothelial permeability (1).

H2O2, produced by the spontaneous or enzymatic dismutation of O-2, is lipid soluble and readily diffuses into endothelial cells, where it can react with ferrous iron to produce the extremely toxic · OH. Approximately 40% of the H2O2 formed by activated polymorphonuclear leukocytes can be oxidized by myeloperoxidase (MPO) in the presence of Cl-, the most abundant halide in plasma, to HOCl (6), which is highly reactive and does not accumulate in biologic systems. HOCl is a powerful oxidant that is ~ 100-fold more potent as an antimicrobial compound than H2O2 (7) and that can degrade structural proteins and inactivate enzymes (8). Although the effects of H2O2 on vascular endothelial permeability have been studied extensively, the effects of HOCl are represented by only one study (5). The purpose of the present study was to compare and contrast the effects of H2O2 and HOCl on the permeability of the vascular endothelium.

The first objective was to compare the time course and the degree of alterations in endothelial cell monolayers of protein permeability, electrical resistance, and cell shape induced directly by H2O2 or HOCl. The second objective was to determine if the generation of HOCl by H2O2 and MPO in the presence of Cl- would yield similar results as the direct administration of HOCl. This protocol has been used successfully to induce glomerular injury (9) and simulates the in vivo condition where the release of H2O2 and MPO from polymorphonuclear leukocytes would react in the presence of Cl- to form HOCl at localized sites on the endothelial cell surface. A third objective was to determine if the adenosine 3',5'-cyclic monophosphate (cAMP)-enhancing agents, isoproterenol and 8-bromo-cAMP, could prevent the alterations in endothelial protein permeability induced by HOCl given directly or generated by H2O2 and MPO as well as by H2O2 alone (4, 10).

Diffusive permeability was assessed by the clearance of 125I-labeled albumin across cell monolayers of bovine pulmonary artery endothelial cells. Electrical resistance of these cell monolayers was monitored on-line using a novel methodology known as ECIS (for electric cell-substrate impedance sensor) (11, 12). Alterations in cell shape were viewed live with differential interference-contrast (DIC) microscopy.

    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Endothelial Cell Preparation

Description of the endothelial cells has been outlined in detail elsewhere (13, 14). Briefly, bovine pulmonary artery endothelial cells (CCL-209; American Type Culture Collection, Rockville, MD) were obtained at passage 16; cultured in Dulbecco's modified Eagle's medium (DMEM; GIBCO, Grand Island, NY), 20% donor calf serum (GIBCO), gentamycin (50 mg/ml; M.A. Bioproducts, Walkerville, MD), and modified Eagle's nonessential amino acids (10 mM; GIBCO); and used between passages 19 and 24.

Albumin Clearance Measurement

Endothelial cells (75,000) were grown to confluence (3 to 4 d) on sterilized, Transwell filters (0.33 cm2, 0.4-µm pore size; Costar, Cambridge, MA). Twenty-four hours before the experiment, DMEM was removed by aspiration and replaced with DMEM without phenol red. The well or luminal compartment containing cells and filter was floated in a stirred 25-ml abluminal compartment, with the compartments separated by the polycarbonate filter lined with the confluent, endothelial cell monolayer. Both compartments contained DMEM without phenol red, 0.5% bovine serum albumin (Sigma Chemical Co., St. Louis, MO) and 20 mM HEPES and were heated to 37° C. This experimental apparatus was designed to study transendothelial transport in the absence of hydrostatic and oncotic pressure gradients, as described previously (13). Measurement of the clearance (microliters per minute) of 125I-labeled albumin was used as an assessment of changes in the diffusive permeability of albumin across the endothelial cell monolayers.

Clearance of 125I-labeled albumin was determined after treatment of the endothelial cells with Hanks' balanced salt solution (HBSS, medium control; GIBCO), H2O2 (10 to 200 µM; Sigma), HOCl (1 to 100 µM; Sigma), MPO (0.75 U/ml; 1 U is the amount of enzymatic activity that causes a change of 1 absorbance unit of the substrate, guaiacol, per minute) then 10 to 100 µM H2O2, isoproterenol hydrochloride (10 µM; Sigma), 8-bromo-cAMP (1 mM; Sigma), and MPO (a gift from Dr. Beulah Gray, University of Minnesota, Minneapolis, MN). The concentration of H2O2 was determined by spectrophotometric analysis at 240 nm with an extinction coefficient of 43.6 M-1 · cm-1 (16). H2O2 was measured in HBSS (1.26 mM CaCl2, 5.37 mM KCl, 0.441 mM KH2PO4, 0.811 mM MgSO4, 137 mM NaCl, 0.342 mM Na2HPO4, 4.17 mM NaHCO3; pH 7.4) using the dye xylenol orange (16). The concentration of HOCl was determined using the spectrophotometric assay for chloride-containing compounds, as described by Chesney and colleagues (17). HOCl was incubated directly with the cells for 10 min after the wells containing the cell monolayers were immersed three times in HBSS to remove serum proteins in the medium. The cell monolayers were immersed a fourth time to remove any residual HOCl and then 125I-labeled albumin clearance was measured for 30 min. This same experimental procedure was used when HOCl was produced by the reduction of H2O2 by MPO.

Analysis of the transvascular clearance of 125I-labeled albumin has been described in detail elsewhere (13). Briefly, the total activity of the abluminal chamber was expressed as a volume of the luminal chamber that was cleared of the albumin tracer into the lower chamber. The clearance volume of albumin over time, equal to the clearance in microliters per minute, was determined by weighted least-square non-linear regression (BMDP Statistical Software, Berkeley, CA). The radioactivity of all samples was measured with an LKB/ Wallac 1272 Clinigamma Counter (Gaithersburg, MD).

125I-labeled albumin was prepared with Na-125I and bovine serum albumin by the chloramine-T procedure, as described previously (18). Bovine serum albumin was passed over a Blue Sepharose affinity column to remove immunoglobulin contamination. To ensure that monomeric albumin was used in these experiments, albumin was passed over a Sephacryl 200 column and the purity checked using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. After iodination, the 125I-labeled albumin was separated from free 125I by dialysis (25,000 Kd cutoff; Spectrapore, Spectrum, Houston, TX) against normal saline (0.9%) and was maintained under dialysis until the day of the experiment. The 125I-labeled albumin was used only if the percent free was < 0.1%, as determined by comparing isotope stock with filtrate from ultrafiltration cones (CF30; 30,000 Kd cutoff; Amicon, Beverly, MA).

Measurement of the Resistive Portion of Electrical Impedance

Measurement of electrical impedance of endothelial cells grown as a monolayer is based on a technique developed to study dynamic behavior of cells in culture. This novel methodology uses an electric cell-substrate impedance sensor (ECIS) (Applied Biophysics, Troy, NY) (11, 12). Endothelial cells are cultured on small gold electrodes, and culture medium is used as the electrolyte. The small gold electrode, covered by confluent endothelial cells, and a larger gold counter electrode are connected to a phase-sensitive, lock-in amplifier. A 1-V, 4,000-Hz ac signal is supplied through a 1-MOmega resistor to approximate a constant current source of 1 µA. Treating the cell-electrode system as a simple series RC circuit, the measured changes in electrical impedance can be partitioned into a measured in-phase voltage proportional to the resistance and an out-of-phase voltage proportional to capacitive reactance. The resistive portion of impedance is related to the resistance between adjacent cells (or paracellular resistance). Voltage and phase data are stored and processed with a personal computer that controls the output of the amplifier and switches the measurement to different electrodes in the five different wells during the course of an experiment.

Endothelial cells (80,000) were grown to confluence (3 to 4 d) on 1% gelatin-coated wells (8 mm in diameter), with each of the five wells containing a small gold electrode (10-3 cm2). Twenty-four hours before the experiment, DMEM was removed by aspiration and replaced with DMEM without phenol red. On the day of the experiment, DMEM without phenol red was removed from each well by aspiration and replaced with 200 µl of HBSS. ECIS wells were placed in the ECIS incubator for 10 min to equilibrate to 37° C and 5% CO2. Cells were preincubated for 10 min with either MPO or HBSS, then electrical impedance measurements, reported in the present study as the resistive portion of impedance, were acquired for 5 min before the addition of HBSS or H2O2. Electrical resistances were then obtained every minute for 1 h after treatment of the endothelial cells with HBSS, 100 µM H2O2, 10-min pretreatment with 0.75 U/ml of MPO followed by 100 µM H2O2 to produce HOCl, and 0.75 U/ml of MPO alone.

Differential Interference-Contrast (DIC) Microscopy

Cell shape was viewed over a 30-min period after incubation with 10 µM HOCl administered directly or by conversion of 400 µM H2O2 with 0.75 U/ml of MPO or with 400 µM H2O2 alone. Cultured endothelial cells seeded on glass coverslips were used for live observations upon reaching confluence (3 to 4 d), as judged by a cuboidal appearance and fluorescent staining with Calcein AM. The cell-seeded coverslips were inverted on glass slides, supported on and elevated from the slides on two sides of the coverslips by tape, and viewed with a Nikon Microphot SA microscope (Nikon Inc., Melville, NY) using 20, 40, 60, and 100× objectives equipped with DIC optics. Incubation of the cell monolayers at 37° C with the test oxidants was performed on the microscope stage by applying 40 µl of the solution on one side of the inverted coverslip while gently withdrawing it by means of filter paper on the opposite side.

To observe reproducible changes in cell shape with H2O2, cell-seeded coverslips were incubated directly in the incubator while lying in a 35-mm petri dish. Different coverslips were then viewed every 5 min for 30 min to record changes in cell shape.

Statistics

Each albumin clearance study consisted of at least three experiments done on different days with four to six cell monolayers per group. The electrical resistance study consisted of three experiments done on different days with one to two cell monolayers per group. Data were analyzed in two ways, as raw data by two-way analysis of variance and as normalized data after log transformation by one-way analysis of variance (19). Differences among treatments or groups within treatments were analyzed further by the Newman-Keuls multiple range test, and differences among treatments or groups from the DMEM-control group were analyzed by the Dunnett's multiple range test. Statistical significance was set at p < 0.05.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

125I-labeled Albumin Clearance Measurements

Incubation of endothelial cell monolayers for 60 min with 10, 50, and 100 µM H2O2 produced a dose-related increase in the transendothelial clearance of 125I-labeled albumin. Doses of H2O2 of 50 and 100 µM consistently increased (p < 0.05) albumin clearance when compared with the HBSS control value (Figure 1). This increase in the diffusive permeability of the endothelium to albumin occurred within the first 30 min of the experiment and persisted for an additional 30 min, as determined from analysis of the data from 10 to 30 min and from 30 to 60 min, respectively (data not shown).


View larger version (14K):
[in this window]
[in a new window]
 
Figure 1.   H2O2 induced a dose-response increase in 125I-labeled albumin clearance upon incubation with pulmonary artery endothelial cells for 30 min. Measurement of albumin clearance coincided with incubation of H2O2. Bars are means ± SE with at least nine cell monolayers per group. HBSS: vehicle control. *p < 0.05 from HBSS.

The effect of HOCl on albumin clearance was assessed using two different protocols, both of which yielded similar results. Firstly, HOCl at doses of 1, 10, 50, and 100 µM was incubated directly with endothelial cell monolayers for 10 min and albumin clearance assessed for 30 min. HOCl consistently increased (p < 0.05) albumin clearance at doses of 50 and 100 µM, whereas 10 µM produced a variable response (Figure 2). Secondly, HOCl was produced by the reduction of H2O2 at 10, 25, 50, and 100 µM by 0.75 U/ml of MPO in the presence of Cl- in HBSS. After the 10-min incubation of MPO with the four doses of H2O2, no detectable H2O2 remained, suggesting complete conversion of H2O2 to HOCl. The direct incubation of H2O2 at these four doses caused only slight increases in albumin clearance from the HBSS control value (Figure 3). The conversion to 25, 50, and 100 µM HOCl by MPO and H2O2 increased (p < 0.05) albumin clearance by as much as twofold greater than the H2O2 control groups (Figure 3).


View larger version (13K):
[in this window]
[in a new window]
 
Figure 2.   HOCl induced a dose-response increase in 125I-labeled albumin clearance upon incubation with endothelial cells for 10 min. Albumin clearance was measured for 30 min immediately after incubation of endothelial cells with HOCl for 10 min in serum-free medium. Bars are means ± SE with 24 cell monolayers per group. HBSS: vehicle control. *p < 0.05 from HBSS.


View larger version (19K):
[in this window]
[in a new window]
 
Figure 3.   HOCl produced from H2O2 by pretreatment with 0.75 U/ml of MPO and Cl- induced a dose- response increase in 125I-labeled albumin clearance upon incubation with endothelial cells for 10 min. Measurement of albumin clearance for H2O2 coincided with incubation of H2O2 and for HOCl occurred immediately after 10-min production of HOCl by H2O2 and MPO. Bars are means ± SE with 10 cell monolayers per group. HBSS: vehicle control. *p < 0.05 from corresponding dose of H2O2.

Electrical Resistance Measurements

Real-time measurements of electrical resistance of endothelial monolayers incubated with 100 µM H2O2 or 100 µM HOCl (produced by MPO, H2O2, and Cl-) revealed that H2O2 caused a slower and smaller decrease in resistance in comparison with HOCl (Figure 4). H2O2 decreased (p < 0.05) resistance by 30% within 31 min, whereas HOCl decreased (p < 0.05) resistance by 50% within 7 min. Electrical resistances were significantly different between the two groups at all time points.


View larger version (21K):
[in this window]
[in a new window]
 
Figure 4.   HOCl, produced from H2O2 and MPO, rapidly and H2O2 slowly decreased electrical resistance of endothelial cell monolayers. Values are means ± SE of temporal changes in resistance for each of four groups with three cell monolayers per group. Arrow depicts time (5 min) of addition of H2O2 or production of HOCl. HBSS: vehicle control. *p < 0.05 from 0 min. +p < 0.05 from H2O2 group (triangles).

Cell Morphology

Changes in cell shape were visualized live with DIC microscopy. The time course and degree of change in cell shape induced by the two oxidants correlated well with the ECIS measurements. H2O2 (400 µM) caused a relatively slow change (~ 25 min) in cell shape (Figure 5). In contrast, cells retracted from one another within 3 min when HOCl was administered directly (10 µM HOCl) or produced indirectly (~ 400 µM HOCl) via conversion of 400 µM H2O2 by MPO (Figure 5). HOCl caused more cells as viewed in an objective field to change shape, greater retraction of cells, and the formation of more intercellular strands.


View larger version (124K):
[in this window]
[in a new window]
 
Figure 5.   DIC micrographs show that 400 µM H2O2 (B: 20 min; C: 25 min) induced a relatively slow change in cell shape within 25 min (C) with fewer intercellular strands compared with 10 µM HOCl given directly (E: 2 min; F: 7 min) or ~ 400 µM HOCl produced by conversion of 400 µM H2O2 with 0.75 U/ml of MPO (H: 1 min; I: 5 min). A: HBSS control; D: HOCl control; G: MPO control. Original magnification: ×500. Bar = 50 µM.

Attenuation of the Oxidant Response with Isoproterenol and 8-Bromo-cAMP

Co-incubation of 10 µM isoproterenol or 1 mM 8-bromo-cAMP prevented the increase in albumin clearance induced by 50 and 200 µM H2O2 (Figure 6). The permeability-decreasing effect of isoproterenol and 8-bromo-cAMP was not as dramatic when HOCl was incubated directly with the endothelial cell monolayers. 8-Bromo-cAMP prevented the increase in albumin clearance induced by 25 µM HOCl and attenuated (p < 0.05) the increase induced by 50 µM HOCl (Figure 7). Isoproterenol slightly attenuated the response at both doses, but the differences were not significant (data not shown). However, 8-bromo-cAMP almost completely prevented the increase in albumin clearance when HOCl was generated by conversion of 50 µM H2O2 by MPO (Figure 8).


View larger version (28K):
[in this window]
[in a new window]
 
Figure 6.   Co-treatment of 10 µM isoproterenol (ISO) or 1 mM 8-bromo-cAMP (cAMP) prevented the increase in 125I-labeled albumin clearance induced by H2O2. Bars are means ± SE with at least 15 cell monolayers per group. HBSS: vehicle control. *p < 0.05 from HBSS. +p < 0.05 from corresponding dose of H2O2.


View larger version (30K):
[in this window]
[in a new window]
 
Figure 7.   Co-treatment of 1 mM 8-bromo-cAMP (cAMP) prevented and attenuated, respectively, the increase in 125I-labeled albumin clearance induced by 25 and 50 µM HOCl. Albumin clearance was measured for 30 min immediately after co-incubation of HOCl and 8-bromo-cAMP with endothelial cells for 10 min in serum-free medium. Bars are means ± SE with 15 cell monolayers per group. HBSS: vehicle control. *p < 0.05 from HBSS. +p < 0.05 from corresponding dose of HOCl.


View larger version (17K):
[in this window]
[in a new window]
 
Figure 8.   Pretreatment with 1 mM 8-bromo-cAMP (cAMP) prevented the increase in 125I-labeled albumin clearance induced by HOCl produced by conversion of 25 µM H2O2 by MPO. Brackets differentiate pretreated agents (below) and post-treated agents (above) for each group of cell monolayers. Bars are means ± SE with 10 cell monolayers per group. HBSS: vehicle control. *p < 0.05 from corresponding MPO/HBSS control. +p < 0.05 from corresponding MPO/H2O2 experimental group.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The objectives of the present study were: (1) to compare the effects of H2O2 and HOCl with respect to relative potencies and the time course and magnitude of changes in protein permeability, electrical resistance, and shape change; (2) to determine if the production of HOCl by the conversion of H2O2 by MPO in the presence of Cl- would yield similar results as the direct administration of HOCl; and (3) to determine if cAMP-enhancing agents could prevent the increase in endothelial protein permeability induced by HOCl given directly or generated by H2O2 and MPO as well as by H2O2 alone. HOCl caused rapid, within 1 to 3 min, changes in cell shape and electrical resistance, whereas H2O2 required ~ 30 min to induce these changes. HOCl produced greater increases in endothelial protein permeability and decreases in electrical resistance and more extensive cell retraction at much lower concentrations than H2O2. Generation of HOCl by the conversion of H2O2 with MPO produced results similar to the direct administration of HOCl. The increase in endothelial protein permeability induced by H2O2 was prevented by isoproterenol and 8-bromo-cAMP, but the increased permeability induced by HOCl was prevented only by 8-bromo-cAMP. These findings demonstrate that HOCl is a more potent oxidant than H2O2 in altering endothelial cell shape and permeability and that an elevation in the intracellular level of cAMP can prevent the increase in endothelial protein permeability induced by either oxidant.

Previous studies have shown that both H2O2 and HOCl increase endothelial protein permeability in vitro (1, 5) and that cAMP-enhancing agents can prevent the increased permeability induced by H2O2 (4, 10). H2O2 has been reported to increase permeability in a dose range from 50 to 100 µM, with doses > 100 µM causing cellular damage as assessed by release of lactate dehydrogenase or 51Cr (1, 20, 21). HOCl was found to increase permeability at doses equal to and greater than 25 µM (5). The present study confirms these findings and, in addition, directly compares the potency and temporal response of these two oxidants using four different methodologies. First, the potency of these two oxidants was compared by the measurement of endothelial protein permeability. The direct administration of HOCl produced a variable increase in permeability at 10 µM and consistent increases at 25, 50, and 100 µM, whereas H2O2 produced consistent increases at 50 and 100 µM. Secondly, HOCl produced by conversion of H2O2 with MPO significantly increased endothelial protein permeability at doses of 25, 50, and 100 µM compared directly to the same doses of H2O2 administered alone as the control groups. At 50 and 100 µM, HOCl doubled the protein permeability of the H2O2 control groups. Thirdly, the potency and time course of changes in endothelial electrical resistance were compared directly using the ECIS apparatus. HOCl caused almost an immediate decrease in electrical resistance, whereas H2O2 required ~ 30 min to induce a significant change in resistance. Furthermore, HOCl decreased endothelial electrical resistance to a twofold greater extent than H2O2. Fourthly, HOCl caused a more rapid (within 3 min) and extensive alteration in cell shape than H2O2 (~ 30 min), as depicted by a greater number of and wider intercellular gaps and more extensive formation of intercellular strands. The dose of HOCl (10 µM) that readily produced cell retraction was much lower than that required for H2O2 (400 µM). These four comparisons demonstrate that HOCl induces a more rapid and potent change in electrical resistance, protein permeability, and shape change of endothelial cell monolayers than H2O2.

Similar findings with regard to the time course leading to cellular damage and potency of these two oxidants have been reported for murine macrophage-like tumor cells (P388D1) exposed to HOCl and H2O2 (8). Low concentrations (10 to 20 µM) of HOCl caused oxidation of plasma membrane sulfhydryls and disturbances of plasma membrane functions such as inactivation of glucose uptake, loss of cellular K+, and an increase in cell volume. Higher concentrations led to generalized oxidation of sulfhydryl, methionine, and tryptophan residues, ATP depletion, and cell lysis. H2O2 on the other hand, induced sulfhydryl oxidation of glyceraldehyde-3-phosphate dehydrogenase, depletion of ATP, degradation of NAD, and strand breaks in DNA. Compared with H2O2, which caused cell death after several hours, HOCl induced cell lysis within an hour at one-tenth of the molar concentration (8).

HOCl increased endothelial protein permeability when administered either directly or by conversion of H2O2 with MPO. Enzymatic production of HOCl was used to mimic the in vivo production of HOCl by polymorphonuclear leukocytes. A similar protocol has been used to induce glomerular injury in rats (9). MPO was shown by electron microscopy to localize, presumably by electrostatic interactions, to the glomerular capillary wall. Subsequent administration of H2O2 produced a greater than threefold increase in urine protein excretion from the MPO and H2O2 control groups. These investigators concluded that HOCl produced by the conversion of H2O2 by MPO and Cl- may be important in polymorphonuclear leukocyte-mediated glomerulonephritis.

Under ideal conditions, the conversion of H2O2 to HOCl catalyzed by MPO in the presence of Cl- should be one-to-one. Under physiologic conditions and in the present study, probably not all of the H2O2 was converted to HOCl. Some of the H2O2 was inaccessible to MPO because it had already diffused into the cell. Furthermore, HOCl interferes with its own production by inhibiting the reduction of H2O2 by MPO. Although the added H2O2 was not detectable, using the xylenol orange assay, after conversion by MPO to HOCl, most likely all of the H2O2 was not converted to HOCl. Thus, the comparisons of potency and temporal changes between H2O2 and HOCl produced indirectly are probably limited by the fact that not all of the H2O2 was converted by MPO to HOCl. However, this indirect method of production of HOCl is probably required for studies involving intact animals or isolated lungs perfused with protein, since proteins scavenge HOCl. Furthermore, this indirect production of HOCl simulates the in vivo condition whereby polymorphonuclear leukocytes produce HOCl via the release of MPO, which binds electrostatically to endothelial cells, and H2O2.

We noted that the doses of H2O2 from 10 to 200 µM did not always produce consistent increases in protein permeability. This measurement is determined by linear regression of radioactive counts taken by sampling the abluminal chamber every 5 min for 60 min. Linear regression analysis from the first and second 30-min periods of the 1-h experiments resulted in similar increases in endothelial protein permeability induced by H2O2. With the introduction of the ECIS apparatus in the laboratory, it became apparent that the slower onset and reversible nature of the H2O2 response could influence our measurement of protein permeability. Both H2O2 and HOCl have been shown by other investigators to produce reversible changes in endothelial cell shape. For H2O2, changes in cell shape were maximal within 4 to 6 h and reversible by 24 h (22). HOCl caused changes in cell shape that were noticeable within 2 to 6 min and reversible by 4 h (5). The reversible response of HOCl was observed with noncytotoxic concentrations of 10 and 25 µM and when the HOCl was incubated with the cells for 2 min but not when incubated for 6 min. We have also observed using the ECIS apparatus that the H2O2-induced decrease in electrical resistance is reversible within 1 to 2 h (unpublished observations). Thus, a slow and reversible change in endothelial cell shape could readily explain the variable nature of the H2O2 response as assessed by the measurement of endothelial protein permeability.

With both oxidants, the changes in endothelial cell shape have been reported to include cell retraction, the formation of thin intercellular strands connecting the separated cells early in the retraction process, and the reorganization of actin microfilaments (1, 5, 22). We also observed cell retraction and the formation of intercellular strands, but more so with HOCl than H2O2. Even more intercellular strands are produced upon incubation of endothelial cells with alpha -thrombin, which induces cell contraction within a minute (unpublished observations). Fluorescence microscopy indicates that these intercellular strands contain cytoplasm, as they take up the vital cytoplasmic dye, Calcein AM, and contain the adherens junctional proteins, actin, vinculin, and plakoglobin (unpublished observations). Although both oxidants caused cell retraction, the differences in time of onset and the extent of intercellular strand formation would suggest that these two oxidants function by different mechanisms. Schraufstatter and associates (8) have demonstrated that HOCl and H2O2 interact with similar and different cellular targets. For example, HOCl reacts with the closest targets, often components of the plasma membrane, whereas H2O2 diffuses freely into cells and causes site-directed damage presumably due to the formation of metal-dependent · OH.

A variety of cAMP-enhancing agents have been used to attenuate the H2O2-induced increase in endothelial permeability in vitro (4, 10). Pretreatment with prostaglandin E1, forskolin, type III and IV phosphodiesterase inhibitors, and beta 2-adrenergic agonists have been effective in the prevention of the H2O2-induced increase in endothelial permeability. There are a number of mechanisms whereby an increase in the intracellular level of cAMP might protect against the H2O2 response. H2O2 has been shown to reduce intracellular levels of ATP (21, 23, 24), NAD (24), and glutathione (20) and activate the inositol phosphate pathway which increases intracellular Ca2+ (25, 26) and activates protein kinase C (1). In an 18-h model of asbestos-induced increase in endothelial permeability to protein, the attenuation of this response by cAMP was associated with a decrease in the level of ATP depletion and the proliferation of endothelial cells but not by any effects on glutathione depletion or production of · OH (27). Inhibition of poly(ADP-ribose) polymerase by 3-aminobenzamide, nicotinamide, or theophylline prevented cytotoxicity of leukocyte cell lines exposed to 1 mM H2O2 (24). The mechanism of action of these inhibitors is not clear but may ultimately lead to an elevation in intracellular cAMP by inhibition of cAMP-dependent phosphodiesterases or by activation of a cAMP-dependent protein kinase (24). cAMP-enhancing agents also reduce the activity of myosin light chain kinase and it is this step in the cell signaling pathway that cAMP probably antagonizes when cAMP functions to block the permeability response induced by thrombin and histamine as well as other agents that work via cell contraction (28, 29).

8-Bromo-cAMP prevented the increased protein permeability induced by either oxidant, whereas isoproterenol failed to modify the HOCl response. Administered as a co-treatment, HOCl as well as H2O2 could directly alter the structure of isoproterenol and/or oxidize the sulfhydryl groups in the beta -adrenergic receptor and subsequently depress the function of the receptor (30). That HOCl may react directly with isoproterenol and is a more potent oxidant than H2O2 might explain why isoproterenol was protective against H2O2 but not HOCl.

    Footnotes

Correspondence and requests for reprints should be addressed to Fred L. Minnear, Ph.D., Department of Physiology and Cell Biology (A-134), 47 New Scotland Ave., Albany Medical College, Albany, NY 12208.

(Received in original form October 31, 1996 and in revised form May 15, 1997).

Acknowledgments: The writers thank Drs. Ivar Giaever and Charles Keese of Applied Biophysics (Troy, NY) for the use of the ECIS apparatus, Christine Morton and Corinne Giunta for their technical assistance, Wendy Ward for her editorial assistance, and Dr. Beulah Gray for her generous gift of myeloperoxidase.

Supported by Grants HL-38894 and AHA-91-037G, and, in part, by AHA New York State Affiliate-970127. L. Ochoa was supported by an NRSA Postdoctoral Training Grant (T32-HL-07529). G. Waypa was supported by an NIH Predoctoral Training Grant (T32-HL-07194).

    References
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1. Siflinger-Birnboim, A., M. S. Goligorsky, P. J. Del Vecchio, and A. B. Malik. 1992. Activation of protein kinase C pathway contributes to hydrogen peroxide-induced increase in endothelial permeability. Lab. Invest 67: 24-30 [Medline].

2. Johnson, K. J., J. C. Fantone III, J. Kaplan, and P. A. Ward. 1981. In vivo damage of rat lungs by oxygen metabolites. J. Clin. Invest 67: 983-993 .

3. Del Maestro, R. F., J. Bjork, and K.-E. Arfors. 1981. Increase in microvascular permeability induced by enzymatically generated free radicals. Microvasc. Res 22: 255-270 [Medline].

4. Seeger, W., T. Hansen, R. Rossig, T. Schmehl, H. Schutte, H.-J. Kramer, D. Walmrath, N. Weissmann, F. Grimminger, and N. Suttorp. 1995. Hydrogen peroxide-induced increase in lung endothelial and epithelial permeability: effect of adenylate cyclase stimulation and phosphodiesterase inhibition. Microvasc. Res 50: 1-17 [Medline].

5. Tatsumi, T., and H. Fliss. 1994. Hypochlorous acid and chloramines increase endothelial permeability: possible involvement of cellular zinc. Am. J. Physiol 267: H1597-H1607 [Abstract/Free Full Text].

6. Weiss, S. J., R. Klein, A. Slivka, and M. Wei. 1982. Chlorination of taurine by human neutrophils: evidence for hypochlorous acid generation. J. Clin. Invest 70: 598-607 .

7. Chesney, J., J. W. Eaton, and J. R. Mahoney Jr.. 1996. Bacterial glutathione: a sacrificial defense against chlorine oxidants. J. Bacteriol 178: 2131-2135 [Abstract/Free Full Text].

8. Schraufstatter, I. U., K. Browne, A. Harris, P. A. Hyslop, J. H. Jackson, O. Quehenberger, and C. G. Cochrane. 1990. Mechanisms of hypochlorite injury of target cells. J. Clin. Invest 85: 554-562 .

9. Johnson, R., J., W. G. Couser, E. Y. Chi, S. Adler, and S. J. Klebanoff. 1987. New mechanism for glomerular injury: myeloperoxidase-hydrogen peroxide-halide system. J. Clin. Invest. 79:1379-1387.

10. Suttorp, N., U. Weber, T. Welsch, and C. Schudt. 1993. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J. Clin. Invest 91: 1421-1428 .

11. Tiruppathi, C., A. B. Malik, P. J. Del Vecchio, C. R. Keese, and I. Giaever. 1992. Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function. Proc. Natl. Acad. Sci. U.S.A 89: 7919-7923 [Abstract/Free Full Text].

12. Giaever, I., and C. R. Keese. 1984. Monitoring fibroblast behavior in tissue culture with an applied electric field. Proc. Natl. Acad. Sci. U.S.A 81: 3761-3764 [Abstract/Free Full Text].

13. Cooper, J. A., P. J. Del Vecchio, F. L. Minnear, K. E. Burhop, W. M. Selig, J. G. N. Garcia, and A. B. Malik. 1987. Measurement of albumin permeability across endothelial monolayers in vitro. J. Appl. Physiol 62: 1076-1083 [Abstract/Free Full Text].

14. Minnear, F. L., M. A. A. DeMichele, D. G. Moon, C. L. Rieder, and J. W. Fenton II.. 1989. Isoproterenol reduces thrombin-induced pulmonary endothelial permeability in vitro. Am. J. Physiol 257: H1613-H1623 [Abstract/Free Full Text].

15. Minnear, F. L., M. A. A. DeMichele, S. Leonhardt, T. A. Anderson, and M. Teitler. 1993. Isoproterenol antagonizes endothelial permeability induced by thrombin and thrombin receptor peptide. J. Appl. Physiol 75: 1171-1179 [Abstract/Free Full Text].

16. Jiang, Z.-Y., A. C. S. Woollard, and S. P. Wolff. 1990. Hydrogen peroxide production during experimental protein glycation. F.E.B.S. Lett 268: 69-71 [Medline].

17. Chesney, J. A., J. R. Mahoney Jr., and J. W. Eaton. 1991. A spectrophotometric assay for chlorine-containing compounds. Anal. Biochem 196: 262-266 [Medline].

18. Bocci, V.. 1964. Efficient labelling of serum proteins with 131I using chloramine-T. Int. J. Appl. Radiat. Isot 15: 449-456 [Medline].

19. Wallenstein, S., C. L. Zucker, and J. L. Fleiss. 1980. Some statistical methods useful in circulation research. Circ. Res 47: 1-9 [Abstract/Free Full Text].

20. Bhat, G. B., S. B. Tinsley, J. K. Tolson, J. M. Patel, and E. R. Block. 1992. Hypoxia increases the susceptibility of pulmonary artery endothelial cells to hydrogen peroxide injury. J. Cell. Physiol 151: 228-238 [Medline].

21. Varani, J., S. H. Phan, D. F. Gibbs, U. S. Ryan, and P. A. Ward. 1990. H2O2-mediated cytotoxicity of rat pulmonary endothelial cells: changes in adenosine triphosphate and purine products and effects of protective interventions. Lab. Invest 63: 683-689 [Medline].

22. Bradley, J. R., S. Thiru, and J. S. Pober. 1995. Hydrogen peroxide-induced endothelial retraction is accompanied by a loss of the normal spatial organization of endothelial cell adhesion molecules. Am. J. Pathol 147: 627-641 [Abstract].

23. Spragg, R. G., D. B. Hinshaw, P. A. Hyslop, I. U. Schraufstatter, and C. G. Cochrane. 1985. Alterations in adenosine triphosphate and energy charge in cultured endothelial and P388D1 cells after oxidant injury. J. Clin. Invest 76: 1471-1476 .

24. Schraufstatter, I. U., P. A. Hyslop, D. B. Hinshaw, R. G. Spragg, L. A. Sklar, and C. G. Cochrane. 1986. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. U.S.A 83: 4908-4912 [Abstract/Free Full Text].

25. Hinshaw, D. B., J. M. Burger, B. C. Armstrong, and P. A. Hyslop. 1989. Mechanism of endothelial cell shape change in oxidant injury. J. Surg. Res 46: 339-349 [Medline].

26. Hyslop, P. A., D. B. Hinshaw, I. U. Schraufstatter, L. A. Sklar, R. G. Spragg, and C. G. Cochrane. 1986. Intracellular calcium homeostasis during hydrogen peroxide injury to cultured P388D1 cells. J. Cell. Physiol 129: 356-366 [Medline].

27. Israbian, V. A., S. A. Weitzman, and D. W. Kamp. 1994. Dibutyryl cAMP attenuates asbestos-induced pulmonary epithelial cell cytotoxicity and decline in ATP levels. Am. J. Physiol 267: L518-L525 [Abstract/Free Full Text].

28. Sheldon, R., A. Moy, K. Lindsley, S. Shasby, and D. M. Shasby. 1993. Role of myosin light-chain phosphorylation in endothelial cell retraction. Am. J. Physiol 265: L606-L612 [Abstract/Free Full Text].

29. Garcia, J. G. N., H. W. Davis, and C. E. Patterson. 1995. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J. Cell. Physiol 163: 510-522 [Medline].

30. Engels, F., R. S. Oosting, and F. P. Nijkamp. 1987. Dual effects of Haemophilus influenzae on guinea pig tracheal beta-adrenergic receptor function: involvement of oxygen-centered radicals from pulmonary macrophages. J. Pharmacol. Exp. Ther 241: 994-999 [Abstract/Free Full Text].





This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
T. A. Sutton, H. E. Mang, S. B. Campos, R. M. Sandoval, M. C. Yoder, and B. A. Molitoris
Injury of the renal microvascular endothelium alters barrier function after ischemia
Am J Physiol Renal Physiol, August 1, 2003; 285(2): F191 - F198.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Qiao, F. Huang, and H. Lum
PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction
Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L972 - L980.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F. L. Minnear, S. Patil, D. Bell, J. P. Gainor, and C. A. Morton
Platelet lipid(s) bound to albumin increases endothelial electrical resistance: mimicked by LPA
Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1337 - L1344.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Gainor, C. A. Morton, J. T. Roberts, P. A. Vincent, and F. L. Minnear
Platelet-conditioned medium increases endothelial electrical resistance independently of cAMP/PKA and cGMP/PKG
Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H1992 - H2001.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Lum and K. A. Roebuck
Oxidant stress and endothelial cell dysfunction
Am J Physiol Cell Physiol, April 1, 2001; 280(4): C719 - C741.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. B. Waypa, C. A. Morton, P. A. Vincent, J. R. Mahoney Jr., W. K. Johnston III, and F. L. Minnear
Oxidant-increased endothelial permeability: prevention with phosphodiesterase inhibition vs. cAMP production
J Appl Physiol, March 1, 2000; 88(3): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Burns, R. Bowden, S. MacDonell, D. Walker, T. Odebunmi, E. Donnachie, S. Simon, M. Entman, and C. Smith
Analysis of tight junctions during neutrophil transendothelial migration
J. Cell Sci., January 1, 2000; 113(1): 45 - 57.
[Abstract] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Lum, H. A. Jaffe, I. T. Schulz, A. Masood, A. RayChaudhury, and R. D. Green
Expression of PKA inhibitor (PKI) gene abolishes cAMPmediated protection to endothelial barrier dysfunction
Am J Physiol Cell Physiol, September 1, 1999; 277(3): C580 - C588.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Lum, Z. Hao, D. Gayle, P. Kumar, C. E. Patterson, and M. D. Uhler
Vascular endothelial cells express isoforms of protein kinase A inhibitor
Am J Physiol Cell Physiol, January 1, 2002; 282(1): C59 - C66.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by OCHOA, L.
Right arrow Articles by MINNEAR, F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by OCHOA, L.
Right arrow Articles by MINNEAR, F. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society